Shorter reflections, LinkedIn series, and commentary on events, trends, and questions we encounter in our daily work. Think of this as our notebook — where ongoing questions meet fresh observations.
3 common mistakes in pharma market access negotiations – and how to avoid them
Market access is often the decisive bottleneck: without successful payer negotiations, even the most innovative product will fail commercially. From m…
Asia-Pacific BioPharma Insights
Country Spotlight Series: Japan Biotech & Pharma Deep Dive Market Overview Japan is one of the most mature and innovation-driven biotech and pharm…
Negotiations in Biotech
In biotech, most negotiations are won or lost long before the first offer is made. After 25+ years as a founder, pharma exec, and investor, I’ve learn…
What restoring a classic car taught me about consulting
In my free time, I restore old Mercedes-Benz cars – such as the R107 SL model. It’s not fast. It’s not efficient. But it teaches me things that …
LinkedIn Local Bonn
What a Thursday! Andreas Folge and I had the pleasure of joining the #LiLoBonn Event last week — a gathering full of curiosity, candid conversations, …
Before every negotiation, map the terrain to get an accurate picture of reality!
To find out how we might help you scout the terrain to prepare and conduct negotiations at the highest level, let’s talk.